Phase 3 Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with advanced melanoma (Stage IIIC, IIID, or IV) that cannot be fully removed by surgery or has spread to other parts of the body, confirmed by a lab test on a tissue sample.
- Your doctor has assessed that you are generally well enough to carry out daily activities with little or no limitation, and your life expectancy is estimated to be more than 6 months.
- You have at least one tumor (or group of tumors) that a surgeon can remove to be used to create a personalised cell therapy called lifileucel.
- After the tumor removal, you still have at least one other measurable area of disease that doctors can track during the trial.
- Your organs (such as kidneys, liver, and heart) are working well enough to safely take part.
- If you or your partner could become pregnant, you must be willing to use a highly effective method of birth control during the trial.
- If you are over 70 years old, you may still be considered after your doctor discusses your case with the trial medical team.
Who may not be able to join:
- Your melanoma started in the eye (uveal or ocular melanoma).
- You have brain metastases (cancer that has spread to the brain) that are causing symptoms and have not been treated.
- You have already received more than one previous treatment course for your melanoma.
- You have previously received any treatment specifically for metastatic (spread) disease.
- If your tumor has a specific gene change called BRAF V600 mutation, and you have only received a type of immune therapy (called ICI) before surgery as a preventative treatment, you may not be eligible (confirm with trial site).
- You have an active serious illness — such as an ongoing infection, seizure disorder, blood clotting disorder, or significant heart, lung, or immune system condition — that your doctor believes could make participation risky.
- You have any condition that weakens your immune system, such as a severe immune deficiency (e.g., SCID) or AIDS.
- You have had another type of cancer diagnosed within the last 3 years, unless it did not need treatment or was fully treated more than 1 year ago and your doctor does not think it is likely to return.
- You have previously had a transplant of an organ or cells from another person.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Iovance Biotherapeutics Study Team, Iovance Biotherapeutics
Phone: 1-844-845-4682
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
5 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Objective Response Rate and Progression Free Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.